ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
---|---|---|---|---|
Delivering on the Promise of Germline Genetic Testing for RUNX1 Variants | University of Washington, Seattle / Abbye McEwen, MD, PhD | RUNX1 Early Career Investigator Grants | 2022 | Washington |
The Role of DNA Methylation in Pediatric Cancer | Fred Hutchinson Cancer Research Center / Scott Diede | Young Investigator Grants | 2010 | Washington |
Self-Management of Cancer-Related Fatigue by Adolescents: Pilot Study of an Evidence Based Educational Resource. | Seattle Children’s Hospital and Regional Medical Center / Catherine Fiona Macpherson | Nurse Researcher Grants | 2008 | Washington |
Restoring RUNX1 Levels in FPD/AML | University of Washington, Seattle / Marshall Horwitz, MD/PhD | RARE Grant Program (Research Accelerating RUNX1 Exploration) | 2016 | Washington |
Novel Antibodies to the C2-set Domain of CD33 for Acute Myeloid Leukemia Immunotherapy | Fred Hutchinson Cancer Research Center / Colin Godwin, MD | Young Investigator Grants | 2018 | Washington |
Serious Morbidity and Financial Outcomes Among Pediatric Cancer Survivors | Fred Hutchinson Cancer Research Center / Beth Mueller, PhD | Epidemiology Grants | 2014 | Washington |
Critical Contributions of CRM1 to Leukemogenesis | University of Vermont / Jessica Linda Heath, MD | Young Investigator Grants | 2015 | Vermont |
TrkB Signaling in the Genesis of Murine Neuroblastoma | University of Vermont / Rae Nishi, PhD | Innovation Grants | 2007 | Vermont |
Pharmacogenomics and Drug Screening Lead to a Novel Targeted Therapy with Potent and Specific Activity Against Mouse Models of MYCN-amplified Neuroblastoma | Virginia Commonwealth University / Anthony Faber, MD & Yael Mosse, MD (CHOP) | Innovation Grants | 2015 | Virginia |
LSD1 Inhibition to Treat T-cell Acute Lymphoblastic Leukemia/Lymphoma | University of Virginia, School of Medicine / Michael Engel, MD/PhD | Reach Grants | 2016 | Virginia |